1. In this case report, two patients who developed
statin-associated
autoimmune myopathy had their
cholesterol levels effectively managed with the novel cholesterol reduction medication evolocumab. 2. The use of this drug did not result in any adverse events for the two patients included in the case study throughout follow-up. Evidence Rating Level: 4 (Below Average) […]